Self-assembled chitosan derived microparticles inhibit tumor angiogenesis and induce apoptosis in Ehrlich-ascites-tumor bearing mice.

Self-assembled microparticles from chitosan (SAMC) was prepared by depolymerization induced by potassium
persulfate. Particle size distribution data showed averaged around 5 μm size and SEM indicated the sequential
formation of “RBC” shaped particles. Soluble SAMC consists of ‘deacetylated’ residues as revealed by 13C NMR.
SAMC showed antitumor efficacy in human breast cancer cell lines through mitigation in cell proliferation,
colony formation and cell migration. Anti-tumor and anti-angiogenic properties of SAMC was found in vivo
Ehrlich ascites tumor (EAT) bearing mice model resulting in tumor growth inhibition (EAT control, 17.4 ml;
SAMC treated, 6.8 ml) and improved survival potency (15 days). Moreover, the decrease in ascites VEGF
secretion (EAT control, 1354 ng; SAMC treated, 351 ng) accompanied with reduction in neovessel formation.
Apoptosis induction by SAMC was confirmed by DNA fragmentation, caspase activities and fluorescence staining
methods respectively. SAMC may be a safe candidate for anti-tumor dietary supplement production in food
industry.